RSSCategory: Patient Advocacy

FDA Delays Final Guidance on Regulating LDTs

| November 25, 2016 | 0 Comments

medpagetoday.com posted a brief but concise article earlier this week on the issue of FDA regulating laboratory developed tests (LDTs). While the FDA has had the ability to regulate these tests since 1976, largely once regarded as “simple and scarce” as the article mentions, not before a draft guidance issued in 2014 has the FDA […]

Continue Reading

Cancer Moonshot Initiative Grounded

| November 23, 2016 | 0 Comments

Previous posts on this matter referenced that even with the funding proposed in the hundreds of millions dollars (estimated $750 million proposal) a lot more would be required. I believe one critic I referenced said that even with that amount of funding, if approved, wouldn’t “get us off the ground” when it came to this […]

Continue Reading

A cancer patient and pathologist — brought together by Twitter — strike up an unlikely connection

| October 27, 2016 | 0 Comments

Courtesy of STAT  By Linnea Olson and Michael Misialek Awesome read about a patient and pathologist exploring lung cancer together. Patients can be their own best advocates while pathologists should have the opportunity to meet their patients. While every surgical pathology accession number is a life, putting a face with a name can be mutually beneficial. […]

Continue Reading

Jessica and a Weekend in California

| October 20, 2016 | 0 Comments

Jessica is a 42-year old wife and mother of 2. She was diagnosed with an aggressive form of breast cancer just over seven years ago and doctors recently declared her with no evidence of disease. As a young woman with breast cancer, she became affiliated with the Young Survival Coalition (YSC) and this year completed […]

Continue Reading

Study Questions Value of Routine Mammograms

| October 13, 2016 | 0 Comments

A recent news brief service recently sent out highlights about a new study published in NEJM that questions the value of mammography for breast cancer screening while critics cited in the news brief call the study “deeply flawed” and suggest keeping with the recommendations. The study was conducted by researchers at Dartmouth and NCI and […]

Continue Reading

Pink Cleats Will Not Cure Cancer

| October 5, 2016 | 0 Comments

Last Friday was the end of the month, end of the quarter, and for some companies and organizations, end of the fiscal year. October, as it used to be called, as in “Mr. October”, would strike at Midnight on Saturday as Pinktober for 31 days, ending in a holiday characterized by black and orange and […]

Continue Reading

Riding a Bike Versus The Hard Part

| October 4, 2016 | 0 Comments

2 weeks ago I mentioned to a prominent cancer researcher at a prominent cancer center in the United States I would be completing 2 200-mile bike rides over the next few weeks with several hundred other folks to raise awareness and funding for breast cancer. He questioned why I would do such a thing – […]

Continue Reading

Crowdsourcing Effort Takes Aim at Metastatic Breast Cancer

| October 4, 2016 | 0 Comments

The AP (10/3, Tanner) reports breast cancer patients are getting involved in a “big new project that aims to gather enormous troves of information about their diseases in hopes of finding new and better ways of treating patients like them – women whose cancer has spread, or metastasized, and left them nearly out of options.” […]

Continue Reading

News of Our Patients Death Have Been Greatly Exaggerated!

| October 3, 2016 | 0 Comments

Dr. Karim Sirgi, MD, MBA, FCAP, Managing Partner and CEO, LambdaX3 International recently wrote the below post on LinkedIn. Karim has kindly agreed to allow me to repost it here to share outside LinkedIn – including our loyal patient following. I wanted to share it here because I think nearly every pathologist can empathize with […]

Continue Reading

Young Survival Coalition Expresses Concern About Overlooked Moonshot Recommedations

| September 30, 2016 | 0 Comments

I haven’t written much about the President’s Cancer Moonshot initiative recently and as much as I would like – perhaps because following some Blue Ribbon Panel recommendations and a large number of organizations and individuals expressing, in general, positive feedback among the cancer community, there hasn’t been a lot of news about next steps.  I […]

Continue Reading

Check Out Vision24 from Leica Biosystems at CAP ’16

| September 20, 2016 | 0 Comments

Continue Reading

Dismissiveness of “Pinktober” Starting Early

| September 9, 2016 | 0 Comments

Last Fall I wrote a couple of posts about the growing disenchantment with ‘Pinkification’ and ‘Pinktober’ referencing the all-out blitz during October to go “Pink” for breast bancer awareness and prevention.  In one of the pieces I mentioned by disenchantment with what happened a number of years ago I saw in clinical practice and last […]

Continue Reading

Help Support Breast Cancer Survivors This Fall

| September 4, 2016 | 0 Comments

Many of you have already been contacted about this in the past few months. Perhaps repeatedly. Through this site, emails, in-person and/or by phone.  And many of you have generously supported these rides and organization. Time is close for the East coast ride and time is closing in on fundraising time.  For those who have […]

Continue Reading

QualityStar, Diagnostic Quality Assurance® PSO, First Anatomic Pathology QA Program To Attain Patient Safety Organization (PSO) Listing by HHS

| August 24, 2016 | 0 Comments

DIAGNOSTIC QUALITY ASSURANCE® The Agency for Healthcare Research and Quality Assurance (AHRQ) has approved the Diagnostic Quality Assurance ® (DQA) listing as a Patient Safety Organization (PSO) by the Secretary of the Department of Health and Human Services (HHS). Diagnostic Quality Assurance® PSO is a component entity of QualityStar, LLC (www.qualitystar.net), and is the first […]

Continue Reading